These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1452502)

  • 1. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
    Bächer K; Schaeffer M; Lode H; Nord CE; Borner K; Koeppe P
    J Antimicrob Chemother; 1992 Sep; 30(3):365-75. PubMed ID: 1452502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.
    Lode H; Müller C; Borner K; Nord CE; Koeppe P
    Antimicrob Agents Chemother; 1992 Jan; 36(1):144-9. PubMed ID: 1590680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
    Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Movahhed H; Tenney J; Martin RR
    Antimicrob Agents Chemother; 1992 Mar; 36(3):552-7. PubMed ID: 1622165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects.
    Barbhaiya RH; Knupp CA; Tenney J; Martin RR; Weidler DJ; Pittman KA
    J Clin Pharmacol; 1990 Oct; 30(10):900-10. PubMed ID: 2229450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.
    Kemmerich B; Warns H; Lode H; Borner K; Koeppe P; Knothe H
    Antimicrob Agents Chemother; 1983 Sep; 24(3):333-8. PubMed ID: 6357074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefepime: a review.
    Van der Auwera P; Santella PJ
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():103-15. PubMed ID: 8150753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
    Pletz MW; Rau M; Bulitta J; De Roux A; Burkhardt O; Kruse G; Kurowski M; Nord CE; Lode H
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3765-72. PubMed ID: 15388432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefepime in patients with the sepsis syndrome.
    Kieft H; Hoepelman AI; Knupp CA; van Dijk A; Branger JM; Struyvenberg A; Verhoef J
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():117-22. PubMed ID: 8150754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
    Abd El-Aty AM; Goudah A; Mouneir SM; Sunwoo YE; Jang JH; Shin JG; Shim JH; Shimoda M
    Vet Res Commun; 2007 Jan; 31(1):67-75. PubMed ID: 17186405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic population study to describe cefepime lung concentrations.
    Breilh D; Saux MC; Delaisement C; Fratta A; Ducint D; Velly JF; Couraud L
    Pulm Pharmacol Ther; 2001; 14(2):69-74. PubMed ID: 11273786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE; Prince RA; Seilheimer DK; Bosso JA
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition kinetics, bioavailability and renal clearance of cefepime in calves.
    Ismail MM
    Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses.
    Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Martin RR
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1118-22. PubMed ID: 2203303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
    Garrelts JC; Wagner DJ
    Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma, urine and skin pharmacokinetics of cefepime in burns patients.
    Sampol E; Jacquet A; Viggiano M; Bernini V; Manelli JC; Lacarelle B; Durand A
    J Antimicrob Chemother; 2000 Aug; 46(2):315-7. PubMed ID: 10933661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.
    Reed MD; Yamashita TS; Knupp CK; Veazey JM; Blumer JL
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1783-7. PubMed ID: 9257761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the pharmacokinetics of cefepime in children.
    Blumer JL; Reed MD; Knupp C
    Pediatr Infect Dis J; 2001 Mar; 20(3):337-42. PubMed ID: 11303847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
    Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
    Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
    Barbhaiya RH; Knupp CA; Pfeffer M; Zaccardelli D; Dukes GM; Mattern W; Pittman KA; Hak LJ
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.